ICD-10 Coding for Adenocarcinoma of Endometrium(C54.1, C54.1B, C54.1M)
Learn about ICD-10 coding for adenocarcinoma of the endometrium, including documentation requirements and common coding pitfalls.
Complete code families applicable to Adenocarcinoma of Endometrium
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C54.1 | Malignant neoplasm of endometrium | Use when adenocarcinoma is confirmed to originate in the endometrium. |
|
| 8380/3 | Endometrioid adenocarcinoma | Use when histology confirms endometrioid subtype. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAdenocarcinoma of Endometrium
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Adenocarcinoma of Endometrium.
Omitting histological subtype in documentation
Impact
Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims due to insufficient documentation.
Mitigation
Ensure pathology reports include histological subtype.
Misclassification of endometrial cancer as unspecified uterine cancer
Impact
Reimbursement: Potential underpayment due to incorrect DRG assignment., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate cancer registry data.
Mitigation
Use C54.1 for endometrial origin, not C54.9.
Histological subtype documentation
Impact
Failure to document specific histological subtypes.
Mitigation
Implement mandatory fields in pathology reports.